Evidence map›Paper›PMID 22781900›Full record

ReviewNature reviews. Molecular cell biology2012

New lives for old: evolution of pseudoenzyme function illustrated by iRhoms.

Colin Adrain, Matthew Freeman

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Molecular cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Structural insights into the activation and inhibition of the ADAM17-iRhom2 complex.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. The Dsc complex and its role in Golgi quality control.Biochemical Society transactions · 2024
    Review
  7. Discovery of a NiNature communications · 2024
    Article
  8. Article
  9. Genome-Wide Identification of the SPP/SPPL Gene Family andInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Emerging functions of pseudoenzymes.The Biochemical journal · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Colin AdrainMedical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, UK.
Matthew Freeman

Funding

Medical Research Council MC_U105178780Medical Research Council U105178780
6 · The paper itself

Abstract

Large-scale sequencing of genomes has revealed that most enzyme families include inactive homologues. These pseudoenzymes are often well conserved, implying a selective pressure to retain them during evolution, and therefore that they have significant function. Mechanistic insights and evolutionary lessons are now emerging from the study of a broad range of such 'dead' enzymes. The recently discovered iRhoms - inactive homologues of rhomboid proteases - have joined derlins and other members of the rhomboid-like clan in regulating the fate of proteins as they pass through the secretory pathway. There is a strong case that dead enzymes, which have been rather overlooked, may be a rich source of biological regulators.

Indexed as

Evolution, MolecularSequence Homology, Amino AcidAnimalsCarrier ProteinsCatalysisDrosophila melanogasterEnzymesGenomeHumansMicePhylogenySelection, GeneticCarrier ProteinsEnzymesiRhom2 protein, mouse

Identifiers

PMID22781900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.